Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 7441 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX

Read more ››
By: PR Newswire Association LLC. - 03 Mar 2024

Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorr

Read more ››
By: GlobeNewswire - 02 Mar 2024

Ultimovacs announces publication of results from NIPU Phase II trial with UV1 vaccination in mesothelioma in European Journal of Cancer

Read more ››
By: GlobeNewswire - 02 Mar 2024
Related companies:  Ultimovacs ASA

Mindpath Health releases Surviving Super Tuesday: How Election Season Can Affect Mental Health and What To Do About It

Read more ››
By: PR Newswire Association LLC. - 02 Mar 2024

Honey & Barry Sherman Legacy Foundation donates $1 million to Scarborough Health Network to innovate diagnostic imaging

Read more ››
By: PR Newswire Association LLC. - 02 Mar 2024

Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2

Read more ››
By: PR Newswire Association LLC. - 02 Mar 2024
Related companies:  Mezzion Pharmaceuticals, Inc

Global Bioprocess Validation Market Research Report 2022-2024 and 2030: Biosimilars Gain from Patent Expiry of Major Drugs, Driving Gains for Bioprocess Validation

Read more ››
By: PR Newswire Association LLC. - 02 Mar 2024

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 Mar 2024
Related companies:  Zentalis Pharmaceuticals, Inc.

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Read more ››
By: GlobeNewswire - 02 Mar 2024
Related companies:  Genmab A/S

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

Read more ››
By: GlobeNewswire - 02 Mar 2024
Related companies:  Adial Pharmaceuticals, Inc.

Europe Cancer Diagnostics Market Sees Promising Growth Amid Rising Demand for Precision Diagnostics - Forecasts to 2031

Read more ››
By: PR Newswire Association LLC. - 02 Mar 2024

Pennant Acquires Two Senior Living Communities in Utah

Read more ››
By: GlobeNewswire - 01 Mar 2024

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  Cytokinetics, Inc.

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  Lyra Therapeutics, Inc.

NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  NurExone Biologic Ltd.

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  X4 Pharmaceuticals, Inc.

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  ClearPoint Neuro, Inc.

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  BioMea Fusion, Inc.

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  G1 Therapeutics, Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  Oric Pharmaceuticals Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑